Tag: cancer vaccines
-
Nanovaccine Shows Promise in Treating HPV-Related Cancers
Breakthrough in HPV-Related Cancer Treatment Scientists at UT Southwestern Medical Center report that a nanoparticle-based vaccine designed to combat cancers caused by the human papillomavirus (HPV) has demonstrated dramatic effects in preclinical studies. The vaccine, built on a nanotechnology platform, target’s HPV-triggered tumors and appears to stimulate the body’s immune system to attack cancer cells…
-
EO2463 Wins FDA Fast Track for Follicular Lymphoma: A New Immunotherapy Hope
FDA Grants Fast Track Designation to EO2463 for Follicular Lymphoma The U.S. FDA has granted Fast Track designation to EO2463, a novel immunotherapy from Enterome, aimed at treating follicular lymphoma (FL), a typically slow-progressing yet incurable form of indolent non-Hodgkin lymphoma. The designation follows encouraging interim results from the ongoing phase 2 SIDNEY trial (NCT04669171)…
-
FDA Fast Track for EO2463 Immunotherapy Brings Hope for Follicular Lymphoma Patients
Overview: A New Immunotherapy Candidate in Follicular Lymphoma The FDA has awarded Fast Track designation to EO2463, Enterome’s novel immunotherapy designed for follicular lymphoma (FL), an indolent but often relapsing form of non-Hodgkin lymphoma. Grounded in promising interim data from the SIDNEY phase 2 trial, EO2463 represents a strategic effort to harness the immune system…
-
Living with cancer in Ireland: how personalized treatment is changing outcomes
Growing a new approach: from one-size-fits-all to personalized cancer care In Ireland, the cancer landscape has shifted dramatically in the last decade. The story of Lydia Whelan, a 32-year-old diagnosed with stage 2 HER2+ breast cancer in 2024, reflects a broader national trend: treatments are becoming more tailored, more precise, and more hopeful for patients…